As of 2026-09-11, the Intrinsic Value of Entheon Biomedical Corp (ENBI.CN) is -0.10 CAD. This ENBI.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.06 CAD, the upside of Entheon Biomedical Corp is -267.35%.
Based on its market price of 0.06 CAD and our intrinsic valuation, Entheon Biomedical Corp (ENBI.CN) is overvalued by 267.35%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.10 - -0.10 | -0.10 | -267.35% |
| DDM - Stable | (0.04) - (0.08) | (0.06) | -201.9% |
| DDM - Multi | (0.03) - (0.04) | (0.04) | -161.6% |
| Market Cap (mil) | 0.83 |
| Beta | 4.00 |
| Outstanding shares (mil) | 13.86 |
| Enterprise Value (mil) | 0.56 |
| Market risk premium | 5.10% |
| Cost of Equity | 31.33% |
| Cost of Debt | 5.00% |
| WACC | 17.51% |